120022-63-1 Usage
General Description
2,5-Difluorobenzenesulfonamide is a chemical compound with the molecular formula C6H5F2NO2S. It is a white crystalline solid that is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. This chemical is a sulfonamide derivative, which means it contains a sulfonamide functional group. Sulfonamides are known for their antibacterial and antifungal properties, and they are often used in the treatment of various infections. 2,5-Difluorobenzenesulfonamide may also have other potential applications in the fields of organic chemistry and materials science due to its unique chemical structure and properties. It is important to handle this compound with care, as it may be harmful if ingested or inhaled.
Check Digit Verification of cas no
The CAS Registry Mumber 120022-63-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,0,2 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 120022-63:
(8*1)+(7*2)+(6*0)+(5*0)+(4*2)+(3*2)+(2*6)+(1*3)=51
51 % 10 = 1
So 120022-63-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H5F2NO2S/c7-4-1-2-5(8)6(3-4)12(9,10)11/h1-3H,(H2,9,10,11)
120022-63-1Relevant articles and documents
Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them
-
Page/Page column 4, (2010/02/17)
Compounds of formula (I): wherein: RCy represents an unsubstituted or substituted cycloalkyl group or cycloalkylalkyl group,R1, R2, R3 and R4, which may be the same or different, each represent a hydrogen or halogen atom or a nitro group; a cyano group; a hydroxy group; an alkoxy group; an alkyl group; an unsubstituted or substituted amino group; a carboxy group; an alkoxycarbonyl group; an aryloxycarbonyl group; an unsubstituted or substituted aminocarbonyl group. Medicinal products containing the same which are useful in treating or preventing conditions treatable by an AMPA receptor modulator.
